Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP143744.RAAaKq0yjpOvUwgZL8ygP-0dH8NoL9O9EcG3FBv3nln4E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP143744.RAAaKq0yjpOvUwgZL8ygP-0dH8NoL9O9EcG3FBv3nln4E130_assertion type Assertion NP143744.RAAaKq0yjpOvUwgZL8ygP-0dH8NoL9O9EcG3FBv3nln4E130_head.
- NP143744.RAAaKq0yjpOvUwgZL8ygP-0dH8NoL9O9EcG3FBv3nln4E130_assertion description "[Quantitation of serusm anti-gp210-C-terminal peptide antibodies is useful for monitoring the effect of ursodeoxycholic acid and for the early identification of patients at high risk for end-stage hepatic failure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP143744.RAAaKq0yjpOvUwgZL8ygP-0dH8NoL9O9EcG3FBv3nln4E130_provenance.
- NP143744.RAAaKq0yjpOvUwgZL8ygP-0dH8NoL9O9EcG3FBv3nln4E130_assertion evidence source_evidence_literature NP143744.RAAaKq0yjpOvUwgZL8ygP-0dH8NoL9O9EcG3FBv3nln4E130_provenance.
- NP143744.RAAaKq0yjpOvUwgZL8ygP-0dH8NoL9O9EcG3FBv3nln4E130_assertion SIO_000772 15710222 NP143744.RAAaKq0yjpOvUwgZL8ygP-0dH8NoL9O9EcG3FBv3nln4E130_provenance.
- NP143744.RAAaKq0yjpOvUwgZL8ygP-0dH8NoL9O9EcG3FBv3nln4E130_assertion wasDerivedFrom lhgdn-20090331 NP143744.RAAaKq0yjpOvUwgZL8ygP-0dH8NoL9O9EcG3FBv3nln4E130_provenance.
- NP143744.RAAaKq0yjpOvUwgZL8ygP-0dH8NoL9O9EcG3FBv3nln4E130_assertion wasGeneratedBy ECO_0000203 NP143744.RAAaKq0yjpOvUwgZL8ygP-0dH8NoL9O9EcG3FBv3nln4E130_provenance.